Bacterial breaches in immune defences and ineffective clearance exacerbate this risk, placing antimicrobial therapy at the ...

Obeticholic acid is under clinical development by Intercept Pharmaceuticals and currently in Phase III for Biliary Atresia.

Regular coffee consumption (2-3 cups/day) protects against liver cirrhosis, reduces fibrosis, prevents liver cancer, and ...

Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according to a study ...

The following is a summary of “Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With ...

Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase I for Irritable Bowel Syndrome.

WHAT YOU CAN DO: Current Akero shareholders who have held Akero shares since on or before September 13, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

Non-alcoholic fatty liver disease (NAFLD), now renamed as Metabolic Associated Steatotic Liver Disease (MASLD), has traditionally been seen as a condition affecting adults. However, alarming data now ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

While the treatment options for this aggressive type ... which are linked to liver cirrhosis and other serious health ... Mechanism of Action of the Hepatitis B and D Virus Cell Entry Inhibitor ...

Liver transplantation should be considered in patients with hepatic failure unresponsive to corticosteroid treatment, decompensated cirrhosis with a Model for End-Stage Liver Disease score of at ...